| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.8M | — |
| Gross Profit | $2.9M | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.1M | -7.5% |
| Operating Income | -$2.9M | +2.6% |
| Pre-tax Income | $421K | +112.9% |
| Income Tax | -$497K | — |
| Net Income | $918K | +128.1% |
| EPS (Basic) | $0.01 | +116.7% |
| EPS (Diluted) | $0.01 | +116.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | +1842.2% |
| Accounts Receivable | $32.5M | — |
| Current Assets | $59.5M | — |
| Current Liabilities | $102.0M | +9774.4% |
| Total Liabilities | $106.6M | — |
| Stockholders' Equity | $44.4M | +6464.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +10.1% |
| Capital Expenditures | $40K | — |
| Investing Cash Flow | $1.2M | — |
| Financing Cash Flow | $2.2M | +23.0% |
| Free Cash Flow | -$1.5M | +7.6% |